Friday, January 30, 2026 | 01:19 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Natco Pharma Ltd / Announcements / BSE

Natco Pharma Ltd

Board Meeting Intimation for Considering The Unaudited Financial Results For The Quarter And Period Ended 31St December 2025 And Declaration Of 3Rd Interim Dividend If Any For FY 2025-26

03:47 PM, 28th Jan 2026

Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the unaudited Financial Results for the quarter and period ended 31st December 2025 and declaration of 3rd Interim Dividend if any for FY 2025-26

More Natco Pharma Ltd Announcements

    View more